Page last updated: 2024-08-24

atorvastatin and Hemangioma, Cavernous, Central Nervous System

atorvastatin has been researched along with Hemangioma, Cavernous, Central Nervous System in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akers, AL; Awad, IA; Cao, Y; Christoforidis, GA; Fam, MD; Flemming, KD; Girard, R; Hanley, DF; Hobson, N; Koenig, JI; Koskimäki, J; Lane, K; Lee, C; Liao, JK; Lyne, SB; McBee, N; Morrison, L; Piedad, K; Polster, SP; Shenkar, R; Sorrentino, M; Stadnik, A; Thompson, RE; Whitehead, KJ; Zeineddine, HA	1

Trials

1 trial(s) available for atorvastatin and Hemangioma, Cavernous, Central Nervous System

Article	Year
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial. Neurosurgery, 2019, 12-01, Volume: 85, Issue:6 Topics: Atorvastatin; Cerebral Hemorrhage; Double-Blind Method; Female; Follow-Up Studies; Hemangioma, Cavernous; Hemangioma, Cavernous, Central Nervous System; Humans; Magnetic Resonance Imaging; Male; Proof of Concept Study; Prospective Studies; Protein Kinase Inhibitors; rhoA GTP-Binding Protein; Treatment Outcome	2019

Article

Year

Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial.

Neurosurgery, 2019, 12-01, Volume: 85, Issue:6

Topics: Atorvastatin; Cerebral Hemorrhage; Double-Blind Method; Female; Follow-Up Studies; Hemangioma, Cavernous; Hemangioma, Cavernous, Central Nervous System; Humans; Magnetic Resonance Imaging; Male; Proof of Concept Study; Prospective Studies; Protein Kinase Inhibitors; rhoA GTP-Binding Protein; Treatment Outcome

2019